优化颅内动脉瘤强化定量分析的时间点:多期对比增强血管壁MRI研究
该前瞻性研究纳入34例患者42个未破裂颅内动脉瘤(27个囊状、15个梭形),在注射对比剂后4个连续9分钟期相上测量动脉瘤壁强化指数(WEI)。梭形动脉瘤WEI随时间下降22.0%(p=0.009),囊状动脉瘤WEI在4个期相内保持稳定(p>0.05);AWE分级在8个(30%)囊状和6个(40%)梭形动脉瘤中发生变化。作者结论为梭形动脉瘤应在注射对比剂后立即采集以获得最强AWE,囊状动脉瘤AWE在36分钟内稳定。
要点
- 梭形动脉瘤定量AWE应在注射对比剂后立即采集,以获得最强强化信号。
- 囊状动脉瘤AWE在注射对比剂后36分钟内保持稳定,定量时间窗较宽。
- 4个期相中AWE分级在30%囊状和40%梭形动脉瘤发生改变,报告时需注明期相。
核心结论
- 定量分析AWE时,梭形动脉瘤在注射对比剂后立即采集可获得最强AWE,囊状动脉瘤AWE在注射对比剂后36分钟内稳定。
研究设计与样本
- 前瞻性连续纳入未破裂颅内动脉瘤患者,采用1个平扫期和4个连续对比增强期相(每期9分钟)的高分辨率对比增强血管壁MRI,测量脑脊液和动脉瘤壁信号强度以确定动脉瘤壁强化指数(WEI),并按既往分级标准定性分析AWE。
关键影像表现/征象
- 在4个对比增强期相中,AWE分级发生变化见于8个(30%)囊状动脉瘤和6个(40%)梭形动脉瘤。
- 梭形动脉瘤WEI在对比增强后随时间下降22.0%(p=0.009)。
- 囊状动脉瘤WEI在4个对比增强期相中保持恒定(p>0.05)。
诊断标准与关键数值
- AWE定性分析采用既往分级标准,在对比增强图像上进行。
- WEI基于平扫和4个对比增强期相的脑脊液与动脉瘤壁信号强度值计算。
临床应用与阅片要点
- 定量分析梭形动脉瘤AWE时,应选择注射对比剂后立即采集的期相。
- 定量分析囊状动脉瘤AWE时,注射对比剂后36分钟内的期相均可使用。
- 报告AWE分级时需注明所分析的对比增强期相,因分级可随期相变化。
局限性
- 原文指出未来需多中心研究探讨AWE作为动脉瘤生长和破裂新兴标志物的价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Aneurysm wall enhancement (AWE) on high-resolution contrast-enhanced vessel wall MRI (VWMRI) is an emerging biomarker for intracranial aneurysms (IAs) stability. Quantification methods of AWE in the literature, however, are variable. We aimed to determine the optimal post-contrast timing to quantify AWE in both saccular and fusiform IAs.
MATERIALS AND METHODS: Consecutive patients with unruptured IAs were prospectively recruited. VWMRI was acquired on 1 pre-contrast and 4 consecutive post-contrast phases (each phase was 9 min). Signal intensity values of cerebrospinal fluid (CSF) and aneurysm wall on pre- and 4 post-contrast phases were measured to determine the aneurysm wall enhancement index (WEI). AWE was also qualitatively analyzed on post-contrast images using previous grading criteria. The dynamic changes of AWE grade and WEI were analyzed for both saccular and fusiform IAs.
RESULTS: Thirty-four patients with 42 IAs (27 saccular IAs and 15 fusiform IAs) were included. The changes in AWE grade occurred in 8 (30%) saccular IAs and 6 (40%) in fusiform IAs during the 4 post-contrast phases. The WEI of fusiform IAs decreased 22.0% over time after contrast enhancement (p = 0.009), while the WEI of saccular IAs kept constant during the 4 post-contrast phases (p > 0.05).
CONCLUSIONS: When performing quantitative analysis of AWE, acquiring post-contrast VWMRI immediately after contrast injection achieves the strongest AWE for fusiform IAs. While the AWE degree is stable for 36 min after contrast injection for saccular IAs.
CLINICAL RELEVANCE STATEMENT: The standardization of imaging protocols and analysis methods for AWE will be helpful for imaging surveillance and further treatment decisions of patients with unruptured IAs.
KEY POINTS: Imaging protocols and measurements of intracranial aneurysm wall enhancement are reported heterogeneously. Aneurysm wall enhancement for fusiform intracranial aneurysms (IAs) is strongest immediately post-contrast, and stable for 36 min for saccular IAs. Future multi-center studies should investigate aneurysm wall enhancement as an emerging marker of aneurysm growth and rupture.
引用
- Li X, Zhang J, Zhang J, et al. Optimizing timing for quantification of intracranial aneurysm enhancement: a multi-phase contrast-enhanced vessel wall MRI study. Eur Radiol. 2024. PMID: 38856782. doi:10.1007/s00330-024-10827-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。